AMPED Projected Dividend Yield
Ampio Pharmaceuticals Inc ( OTCBB : AMPED )Ampio Pharmaceuticals is a biopharmaceutical company focused on the research, development and improvement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Ampion, Co.'s primary product candidate is a biologic drug, which contains ingredients that target several pathways in the innate immune response characteristic of inflammatory disease. Ampion is in development as an intra-articular injection treatment for severe Osteoarthritis of the Knee; an intravenous and inhaled treatment for COVID-19 patients; and an at-home inhalation treatment for patients with prolonged respiratory symptoms due to COVID-19. 21 YEAR PERFORMANCE RESULTS |
AMPED Dividend History Detail AMPED Dividend News AMPED Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |